|
| [January 10, 2013] |
 |
Agere Executives to Discuss Enhancing Oral Bioavailability Using Amorphous Molecular Dispersions at ExL Pharma's "Enhancing Drug Bioavailability and Solubility" Conference
BEND, Ore. --(Business Wire)--
Agere Pharmaceuticals, Inc., a leading oral bioavailability contract
research and manufacturing organization (CRO/CMO), will present,
facilitate and participate in a panel discussion at ExL Pharma's 2nd
annual conference focused on solubility and bioavailability in Boston,
January 21 - 23, 2013. www.exlpharma.com/bioavailability
|
WHAT:
|
|
|
|
Presentation: "Enhancing Oral Bioavailability using Amorphous
Molecular Dispersions: Industry Implications and Approaches for
Successful cGMP Formulation Development"
|
|
|
|
|
|
|
|
|
|
|
|
-- Formulation paradigm shift in the industry
|
|
|
|
|
|
-- Screening Polymers & Drug Loading: Performance and Stability
|
|
|
|
|
|
-- Small Scale Approaches to amorphous Dispersion formulations
|
|
|
|
|
|
-- Scale-up and cGMP Manufacturing of Solid Dispersion Formulation
|
|
|
|
|
|
|
|
WHO:
|
|
|
|
Marshall Crew, CEO and Founder, Agere Pharmaceuticals, Inc.
|
|
|
|
|
|
|
|
WHEN:
|
|
|
|
Wednesday, January 23, at 3:20 p.m.
|
|
|
|
|
|
|
|
--------------------------------------------------------------------------------
|
|
|
|
|
|
|
|
WHAT:
|
|
|
|
Panel Discussion: "Advancing Amorphous Molecular Dispersions Through
the Clinic: Practical Aspects of cGMP Manufacturing"
|
|
|
|
|
|
|
|
|
|
|
|
-- Product control strategies and risk management for clinical phase
products
|
|
|
|
|
|
-- Dosage form options, excipient selections and decision making for
first in human studies
|
|
|
|
|
|
-- Design development and scale up approaches for successful cGMP
manufacturing
|
|
|
|
|
|
-- Analytical testing and regulatory considerations specific to
amorphous molecular dispersions
|
|
|
|
|
|
|
|
WHO:
|
|
|
|
Marshall Crew, CEO and Founder, Agere (Moderator)
|
|
|
|
|
|
Vince Foley, Director of Quality, Agere
|
|
|
|
|
|
Ryan Minikis, Senior Director Formulation and Chemistry, Agere
|
|
|
|
|
|
Ravi Shanker, Senior Research Investigator, Pfizer, Inc.
|
|
|
|
|
|
|
|
WHEN:
|
|
|
|
Tuesday, January 22, at 10 a.m.
|
|
|
|
|
|
|
All sessions of the conference will be held at the Omni Parker House
Hotel, Boston, MA.
For more information, and to obtain a special conference discount Agere
is extending to clients, please contact Agere at 541-639-8397 or www.agerepharma.com.
About Agere
Agere is a leading CRO/CMO focused on improving the oral bioavailability
of insoluble APIs. The company supports clients from formulation design
and development through cGMP manufacturing for Phase I, Phase IIa and
Phase IIb clinical trials. Agere is expert in solid dispersion
techniques including spray drying and hot melt extrusion (HME), and in a
broad selection of solid dosage forms. All services are delivered on a
fee-for-service basis, and every project the company undertakes is
customized to serve each individual client's requirements. Agere is
located in Bend, OR. For information: www.agerepharma.com.
[ Back To Technology News's Homepage ]
|
Internet Telephony Magazine
Click here to read latest issue
CUSTOMER 
Cloud Computing Magazine
Click here to read latest issue
M2M Evolution Magazine
Call Center/CRM
Info Tech 
IP Communications 
Mobile 
Green 
Satellite 
Robotics 
